Drew Moghanaki/uclahealth.org
Feb 17, 2025, 08:38
Drew Moghanaki: ERRONEOUS Discontinuation of immunotherapy in patients with asymptomatic benign radiation fibrosis
Drew Moghanaki, Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA, shared a post on X:
“Calling on all Medical Oncologists to register for this crucial webinar on Feb 19 providing insights into reasons for ERRONEOUS Discontinuation of immunotherapy in patients with asymptomatic benign radiation fibrosis, and how to better evaluate post-treatment chest CT scans.”
More posts featuring Drew Moghanaki.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 13:07
Feb 21, 2025, 13:06
Feb 21, 2025, 13:03
Feb 21, 2025, 13:00
Feb 21, 2025, 12:53
Feb 21, 2025, 12:41
Feb 21, 2025, 12:39